2-Aminomethyl piperidines as novel urotensin-II receptor antagonists
Authors:
- 1 May 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (9) , 2860-2864
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteriesPeptides, 2004
- Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aortaAtherosclerosis, 2004
- Plasma concentration of urotensin II is raised in hypertensionJournal Of Hypertension, 2004
- Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathyInternational Journal of Cardiology, 2004
- From ‘gills to pills’: urotensin-II as a regulator of mammalian cardiorenal functionTrends in Pharmacological Sciences, 2004
- Plasma Urotensin in Human Systolic Heart FailureCirculation, 2002
- Plasma urotensin II in heart failureThe Lancet, 2002
- Congestive heart failure and expression of myocardial urotensin IIThe Lancet, 2002
- Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissuesJournal Of Hypertension, 2001
- Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14Nature, 1999